Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 79626-79627 [2024-22291]

Download as PDF 79626 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices practices regulation (21 CFR 10.115). The guidance represents the current thinking of FDA on ‘‘Clarification of Radiation Control Regulations for Manufacturers of Diagnostic X-Ray Equipment.’’ It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. II. Electronic Access Persons interested in obtaining a copy of the guidance may do so by downloading an electronic copy from the internet. A search capability for all Center for Devices and Radiological Health guidance documents is available at https://www.fda.gov/medical-devices/ device-advice-comprehensiveregulatory-assistance/guidancedocuments-medical-devices-andradiation-emitting-products. This guidance document is also available at https://www.regulations.gov or https:// www.fda.gov/regulatory-information/ search-fda-guidance-documents. Persons unable to download an electronic copy of ‘‘Clarification of Radiation Control Regulations for Manufacturers of Diagnostic X-Ray Equipment’’ may send an email request to CDRH-Guidance@fda.hhs.gov to receive an electronic copy of the document. Please use the document number GUI01500029 and complete title to identify the guidance you are requesting. III. Paperwork Reduction Act of 1995 While this guidance contains no new collection of information, it does refer to previously approved FDA collections of information. The previously approved collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3521). The collections of information in the following FDA table have been approved by OMB: 21 CFR Part or FDA Form Topic 1002, 1005, 1010, 1020, 1030, 1040, and 1050; form FDA 2579 and form FDA 2877. 800, 801, and 809 ................................................................... 812 ........................................................................................... ‘‘Allegations of Regulatory Misconduct’’ form .......................... Reporting and Recordkeeping for Electronic Products—General Requirements. Labeling ................................................................................... Investigational Device Exemption ........................................... Voluntary Allegations of Regulatory Misconduct .................... Dated: September 25, 2024. Lauren K. Roth, Associate Commissioner for Policy. ACTION: BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2024–N–0758, FDA– 2024–N–2032, FDA–2023–N–3847, and FDA– 2024–N–1201] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals Food and Drug Administration, HHS. The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–8867, PRAStaff@ fda.hhs.gov. SUMMARY: [FR Doc. 2024–22332 Filed 9–27–24; 8:45 am] AGENCY: Notice. OMB Control No. 0910–0025 0910–0485 0910–0078 0910–0769 The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/ PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). SUPPLEMENTARY INFORMATION: TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB Title of collection OMB control No. ddrumheller on DSK120RN23PROD with NOTICES1 New Plant Varieties Intended for Food Use ................................................................................................ Food and Cosmetic Export Certificates ....................................................................................................... Biological Products; General Records and Postmarket Adverse Experience Reporting ............................ Voluntary Total Product Life Cycle Advisory Program Pilot ........................................................................ VerDate Sep<11>2014 17:51 Sep 27, 2024 Jkt 262001 PO 00000 Frm 00126 Fmt 4703 Sfmt 9990 E:\FR\FM\30SEN1.SGM 0910–0583 0910–0793 0910–0308 0910–0930 30SEN1 Date approval expires 9/30/2027 9/30/2027 9/30/2027 9/30/2027 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices Dated: September 24, 2024. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2024–22291 Filed 9–27–24; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Recharter for the Council on Graduate Medical Education Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that the Council on Graduate Medical Education (COGME or Council) is rechartered. DATES: The effective date of the renewed charter is September 30, 2024. FOR FURTHER INFORMATION CONTACT: Shane Rogers, Designated Federal Official (DFO), Division of Medicine and Dentistry, Bureau of Health Workforce, HRSA, 5600 Fishers Lane, Room 15N142, Rockville, Maryland 20857; 301–443–5260; or srogers@ hrsa.gov. SUPPLEMENTARY INFORMATION: COGME makes recommendations to the Secretary of Health and Human Services and Congress on matters specified by section 762 of the Public Health Service Act. Issues addressed by COGME include: (1) the supply and distribution of physicians in the United States; (2) current and future shortages or excesses of physicians in medical and surgical specialties and subspecialties; (3) issues relating to internationalmedical school graduates; (4) appropriate federal policies with respect to the matters specified in (1), (2), and (3) above, including policies concerning changes in the financing of undergraduate and graduate medical education programs and changes in the types of medical education training in graduate medical education programs; (5) appropriate efforts to be carried out by hospitals, schools of medicine, schools of osteopathic medicine, and accrediting bodies with respect to the matters specified in (1), (2), and (3) above, including efforts for changes in undergraduate and graduate medical education programs; and (6) deficiencies in, and needs for improvements in, existing databases concerning the supply and distribution of, and ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:51 Sep 27, 2024 Jkt 262001 postgraduate training programs for, physicians in the United States and steps that should be taken to eliminate those deficiencies. Not later than September 30, 2023, and not less than every 5 years thereafter, COGME shall submit a report on the recommendations made by the committee to the Secretary of Health and Human Services, and to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives. Additionally, COGME encourages entities providing graduate medical education to conduct activities to voluntarily achieve the recommendations of the Council; develops, publishes, and implements performance measures; develops and publishes guidelines for longitudinal evaluations; and recommends appropriation levels for certain programs under title VII of the Public Health Service Act. The renewed charter for COGME was approved on September 18, 2024. The filing date is September 30, 2024. The recharter of COGME gives authorization for the Council to operate until September 30, 2026. A copy of the COGME charter is available on the COGME website at https://www.hrsa.gov/sites/default/files/ hrsa/advisory-committees/graduatemedical-edu/cogme-charter.pdf. A copy of the charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The website address for the FACA database is https://www.facadatabase.gov/. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–22256 Filed 9–27–24; 8:45 am] BILLING CODE 4165–15–P 79627 Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. Name of Committee: Office of AIDS Research Advisory Council. Date: October 24, 2024. Time: 12:00 p.m. to 5:00 p.m. Agenda: Report from the OAR Director; Update on the Development of the NIH Strategic Plan and Research Priorities for HIV Research. Place: Office of AIDS Research, Office of the Director, NIH, 5601 Fishers Lane, Rockville, MD 20852, (Virtual Meeting) https://videocast.nih.gov/. Contact Person: CAPT Mary Glenshaw, Ph.D., M.P.H., OTR/L, Office of AIDS Research, Office of the Director, NIH, 5601 Fishers Lane, Room 2E61, Rockville, MD 20852, (301) 496–0357, OARACinfo@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: September 24, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–22274 Filed 9–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Office of AIDS Research Advisory Council. The meeting will be held as a virtual meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose E:\FR\FM\30SEN1.SGM 30SEN1

Agencies

[Federal Register Volume 89, Number 189 (Monday, September 30, 2024)]
[Notices]
[Pages 79626-79627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22291]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2024-N-0758, FDA-2024-N-2032, FDA-2023-N-3847, and 
FDA-2024-N-1201]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-8867, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at 
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                                         Date approval
        Title of collection          OMB control No.        expires
------------------------------------------------------------------------
New Plant Varieties Intended for            0910-0583          9/30/2027
 Food Use.........................
Food and Cosmetic Export                    0910-0793          9/30/2027
 Certificates.....................
Biological Products; General                0910-0308          9/30/2027
 Records and Postmarket Adverse
 Experience Reporting.............
Voluntary Total Product Life Cycle          0910-0930          9/30/2027
 Advisory Program Pilot...........
------------------------------------------------------------------------



[[Page 79627]]

    Dated: September 24, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-22291 Filed 9-27-24; 8:45 am]
BILLING CODE 4164-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.